A PERK–miR-211 axis suppresses circadian regulators and protein synthesis to promote cancer cell survival
出版年份 2017 全文链接
标题
A PERK–miR-211 axis suppresses circadian regulators and protein synthesis to promote cancer cell survival
作者
关键词
-
出版物
NATURE CELL BIOLOGY
Volume 20, Issue 1, Pages 104-115
出版商
Springer Nature
发表日期
2017-12-07
DOI
10.1038/s41556-017-0006-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Induction of Therapeutic Senescence in Vemurafenib-Resistant Melanoma by Extended Inhibition of CDK4/6
- (2016) A. Yoshida et al. CANCER RESEARCH
- PERK Integrates Oncogenic Signaling and Cell Survival During Cancer Development
- (2016) Yiwen Bu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- PERK Is a Haploinsufficient Tumor Suppressor: Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in Melanoma
- (2016) Dariusz Pytel et al. PLoS Genetics
- The Circadian Protein BMAL1 Regulates Translation in Response to S6K1-Mediated Phosphorylation
- (2015) Jonathan O. Lipton et al. CELL
- MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells
- (2015) Brian J. Altman et al. Cell Metabolism
- Tumor progression and the different faces of the PERK kinase
- (2015) D Pytel et al. ONCOGENE
- PRMT5 Is Required for Lymphomagenesis Triggered by Multiple Oncogenic Drivers
- (2015) Y. Li et al. Cancer Discovery
- Reprogramming of the Circadian Clock by Nutritional Challenge
- (2013) Kristin L. Eckel-Mahan et al. CELL
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- (2013) Balázs Győrffy et al. PLoS One
- ER stress–mediated autophagy promotes Myc-dependent transformation and tumor growth
- (2012) Lori S. Hart et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK)
- (2012) Jeffrey M. Axten et al. JOURNAL OF MEDICINAL CHEMISTRY
- PERK Is Required in the Adult Pancreas and Is Essential for Maintenance of Glucose Homeostasis
- (2012) Y. Gao et al. MOLECULAR AND CELLULAR BIOLOGY
- miR-211 Is a Prosurvival MicroRNA that Regulates chop Expression in a PERK-Dependent Manner
- (2012) Nilesh S. Chitnis et al. MOLECULAR CELL
- Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK
- (2012) A Avivar-Valderas et al. ONCOGENE
- Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses
- (2012) S Bhattacharya et al. ONCOGENE
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- The Cell Biology of the Unfolded Protein Response
- (2011) J. Alan Diehl et al. GASTROENTEROLOGY
- Cell-autonomous circadian clock of hepatocytes drives rhythms in transcription and polyamine synthesis
- (2011) A. Atwood et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nuclear Cyclin D1/CDK4 Kinase Regulates CUL4 Expression and Triggers Neoplastic Growth via Activation of the PRMT5 Methyltransferase
- (2010) Priya Aggarwal et al. CANCER CELL
- PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage
- (2010) E Bobrovnikova-Marjon et al. ONCOGENE
- Circadian Integration of Metabolism and Energetics
- (2010) J. Bass et al. SCIENCE
- The Role of Myc-Induced Protein Synthesis in Cancer
- (2009) D. Ruggero CANCER RESEARCH
- Network Features of the Mammalian Circadian Clock
- (2009) Julie E Baggs et al. PLOS BIOLOGY
- Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
- (2008) Maria Barna et al. NATURE
- N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells
- (2008) A Ushmorov et al. ONCOGENE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started